Natco Pharma Ltd
NSE:NATCOPHARM

Watchlist Manager
Natco Pharma Ltd Logo
Natco Pharma Ltd
NSE:NATCOPHARM
Watchlist
Price: 1 351.35 INR -0.29% Market Closed
Market Cap: 242B INR
Have any thoughts about
Natco Pharma Ltd?
Write Note

Natco Pharma Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Natco Pharma Ltd
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Natco Pharma Ltd
NSE:NATCOPHARM
Interest Income Expense
-â‚ą202m
CAGR 3-Years
-20%
CAGR 5-Years
3%
CAGR 10-Years
5%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Interest Income Expense
-â‚ą1.8B
CAGR 3-Years
-70%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Interest Income Expense
-â‚ą810.4m
CAGR 3-Years
17%
CAGR 5-Years
15%
CAGR 10-Years
5%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Interest Income Expense
â‚ą92m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Interest Income Expense
-â‚ą3B
CAGR 3-Years
1%
CAGR 5-Years
10%
CAGR 10-Years
-10%
M
Mankind Pharma Ltd
NSE:MANKIND
Interest Income Expense
â‚ą1.4B
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Natco Pharma Ltd
Glance View

Market Cap
241.9B INR
Industry
Pharmaceuticals

NATCO Pharma Ltd. engages in the business of pharmaceuticals with research, manufacturing and marketing of finished dosage formulations and active pharmaceutical ingredients. The company is headquartered in Hyderabad, Telangana. The firm is engaged in the development, manufacture and commercialization of complex pharmaceuticals catering to niche therapeutic areas. The firm deals in the production of finished dosage formulations (FDF), which it sells in India, the United States and the Rest of the World, as well as active pharmaceutical ingredients (APIs). Its capabilities include multi-step synthesis, semi-synthetic fusion technologies, production of high-potency APIs and peptides. The firm operates through two segments: pharmaceuticals and agrochemicals. The pharmaceuticals segment, the Company drives its sales through FDFs and APIs. The agrochemicals segment is focused on niche products, including pest management.

NATCOPHARM Intrinsic Value
687.48 INR
Overvaluation 49%
Intrinsic Value
Price

See Also

What is Natco Pharma Ltd's Interest Income Expense?
Interest Income Expense
-202m INR

Based on the financial report for Jun 30, 2024, Natco Pharma Ltd's Interest Income Expense amounts to -202m INR.

What is Natco Pharma Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
5%

Over the last year, the Interest Income Expense growth was -39%. The average annual Interest Income Expense growth rates for Natco Pharma Ltd have been -20% over the past three years , 3% over the past five years , and 5% over the past ten years .

Back to Top